Implantable Pulse Generator Market Report

Market Insights

"The global implantable pulse generator market is projected to grow from USD 85.2 billion in 2020 to USD 136.8 billion by 2026 at a CAGR of around 8.4% during the forecast period.

Wish to get a free sample? Register Here

What is an implantable pulse generator?

An implantable pulse generator is a battery-powered microelectronic medical device that is implanted in the body, delivers electric stimulation to the nervous system to stimulate or block various nerve impulses in the body. This technology is a vital treatment for several medical conditions such as reducing back pain, hypertension, curing diabetes by stopping the dosage of insulin taken daily, and obesity.

Market Drivers

The growing prevalence of diseases and rising demand for innovative alternate therapies are some of the key factors augmenting the demand for implantable pulse generators. Also, other significant drivers propelling the increasing penetration of implantable pulse generators include ease of implants with good reimbursements, better clinical performance, higher patient awareness, and advancing technology. Moreover, the market is likely to grow at a steady pace due to rising use to treat a wide range of medical conditions and diseases during the review period.

Key Players

Key players operating in the implantable pulse generator market are

• Medtronic (Ireland)
• Boston Scientific Corporation (US)
• St. Jude Medical (US)
• Synapse Biomedical (US)
• Nevro Corporation (US)
• Neurosigma (US)
• NeuroPace (US)
• Cyberonics (US)
• BioControl Medical (Israel)

Segments' Analysis

Application Trends

By application, the implantable pulse generator market has been classified into neurovascular diseases, cardiovascular diseases, and orthopedic. Under these, the cardiovascular diseases segment accounted for a significant market share in 2020 and is projected to register significant growth during the review period. This is mainly attributed to growing incidences of cardiovascular diseases (CVDs), the rising cost of cardiac disease management, favorable government policies, and the emergence of technologically advanced pacemakers, which further fosters segment growth.

Regional Insights

By region, the market in North America accounted for a significant market share in 2020 and is projected to grow at a significant CAGR during the assessment period. This is mainly ascribed to the rising prevalence of chronic ailments and cardiovascular diseases, robust healthcare infrastructure, the higher diagnosis rate of the patients, increasing healthcare expenditure, higher adoption of neuromodulation in disease management, and a large number of home healthcare facilities, which further proliferates the regional market growth.

Target Audience

This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the market. The following are the key features of the report:

What deliverables will you get in this report?

Research Methodology

This strategic assessment report, from Stratview Research, provides a comprehensive analysis that reflects today’s composite decks and railings market realities and future market possibilities for the forecast period of 2021 to 2026. The report segments and analyzes the market in the most detailed manner in order to provide a panoramic view of the market. The vital data/information provided in the report can play a crucial role for the market participants as well as investors in the identification of the low-hanging fruits available in the market as well as to formulate the growth strategies to expedite their growth process.

This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools. More than 1000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles, have been leveraged to gather the data. We conducted more than 15 detailed primary interviews with the market players across the value chain in all four regions and industry experts to obtain both qualitative and quantitative insights.